SENGINE PRECISION MEDICINE
SEngine Precision Medicine has engineered an innovative approach to identify and develop the next generation of cancer targeted drugs. Built on its Founders’ work of more than 25 years at the Fred Hutchinson Cancer Research Center, SEngine employs functional genomics and robotic testing of drugs in live patient organoids to match newly developed drugs to individual cancer patients. SEngine strives to fulfill the promise of personalized medicine providing cancer patients with effective, targeted, and less-toxic treatments.
SENGINE PRECISION MEDICINE
Industry:
Biotechnology
Founded:
2015-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.senginemedicine.com
Total Employee:
11+
Status:
Active
Contact:
(833) 736-4163
Total Funding:
21.2 M USD
Technology used in webpage:
Viewport Meta Google Analytics Google Tag Manager Content Delivery Network Global Site Tag Euro Organization Schema AJAX Libraries API Typekit LocalBusiness Schema
Similar Organizations
Elstar Therapeutics
Fulfilling the promise of precision cancer immunotherapy through a powerful new approach to generating multi-functional therapeutics.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Current Advisors List
Current Employees Featured
Founder
Investors List
Bangarang Group
Bangarang Group investment in Series A - SEngine Precision Medicine
Washington Research Foundation
Washington Research Foundation investment in Series A - SEngine Precision Medicine
Vincere Capital Biotech
Vincere Capital Biotech investment in Series A - SEngine Precision Medicine
Alethea Capital Management
Alethea Capital Management investment in Series A - SEngine Precision Medicine
Bangarang Group
Bangarang Group investment in Series A - SEngine Precision Medicine
Bangarang Group
Bangarang Group investment in Venture Round - SEngine Precision Medicine
National Institutes of Health
National Institutes of Health investment in Grant - SEngine Precision Medicine
Official Site Inspections
http://www.senginemedicine.com
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
